{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T01:17:21Z","timestamp":1791249441625,"version":"4.1.0"},"reference-count":47,"publisher":"Oxford University Press (OUP)","issue":"23","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2005,12,1]]},"DOI":"10.1093\/hmg\/ddi395","type":"journal-article","created":{"date-parts":[[2005,10,26]],"date-time":"2005-10-26T07:03:01Z","timestamp":1130310181000},"page":"3673-3684","source":"Crossref","is-referenced-by-count":54,"title":["Induction of HSP70 expression and recruitment of HSC70 and HSP70 in the nucleus reduce aggregation of a polyalanine expansion mutant of PABPN1 in HeLa cells"],"prefix":"10.1093","volume":"14","author":[{"given":"Qishan","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dick D.","family":"Mosser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jnanankur","family":"Bag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2005,10,20]]},"reference":[{"key":"key\n\t\t\t\t20171012064608_DDI395C1","doi-asserted-by":"crossref","unstructured":"Brais, B., Bouchard, J.P., Xie, Y.G., Rochefort, D.L., Chretien, N., Tome, F.M., Lafrenier, R.G., Rommens, J.M., Uyama, E. and Nohira, O. (1998) Short GCT expansions in the PABPN1 gene cause oculopharyngeal muscular dystrophy. Nat. Genet., 18, 164\u2013166.","DOI":"10.1038\/ng0298-164"},{"key":"key\n\t\t\t\t20171012064608_DDI395C2","unstructured":"Brunet, G., Tome, F.M., Samson, F., Robert, J.M. and Fardeau, M. (1990) Oculopharyngeal muscular dystrophy: a census of French families and genealogic study. Rev. Neurol., 146, 425\u2013429."},{"key":"key\n\t\t\t\t20171012064608_DDI395C3","doi-asserted-by":"crossref","unstructured":"Calado, A., Tome, F.M.S., Brais, B., Rouleau, G.A., Kuhn, U., Wahle, E. and Fonseca-Carmo, M. (2000) Nuclear inclusions in oculopharyngeal muscular dystrophy consist of poly(A) binding protein 2 aggregates which sequesters poly(A) RNA. Hum. Mol. Genet., 9, 2321\u20132328.","DOI":"10.1093\/oxfordjournals.hmg.a018924"},{"key":"key\n\t\t\t\t20171012064608_DDI395C4","doi-asserted-by":"crossref","unstructured":"Abu-Baker, A., Messaed, C., Laganiere, J., Gasper, C., Brais, B. and Rouleau, G. (2003) Involvement of the ubiquitin-proteasome pathway and molecular chaperones in oculopharyngeal muscular dystrophy. Hum. Mol. Genet., 12, 2609\u20132623.","DOI":"10.1093\/hmg\/ddg293"},{"key":"key\n\t\t\t\t20171012064608_DDI395C5","doi-asserted-by":"crossref","unstructured":"Wahle, E. (1991) A novel poly(A)-binding protein acts as a specificity factor in the second phase of messenger RNA polyadenylation. Cell, 66, 759\u2013768.","DOI":"10.1016\/0092-8674(91)90119-J"},{"key":"key\n\t\t\t\t20171012064608_DDI395C6","unstructured":"Wahle, E., Listig, A., Jeno, P. and Maurer, P. (1993) Mammalian poly(A)-binding protein II. J. Biol. Chem., 268, 2937\u20132945."},{"key":"key\n\t\t\t\t20171012064608_DDI395C7","doi-asserted-by":"crossref","unstructured":"Wahle, E. (1995) Poly(A) tail length control is caused by termination of processive synthesis. J. Biol. Chem., 270, 2800\u20132808.","DOI":"10.1074\/jbc.270.6.2800"},{"key":"key\n\t\t\t\t20171012064608_DDI395C8","doi-asserted-by":"crossref","unstructured":"Fan, X.P., Dion, P., Laganiere, J., Brais, B. and Rouleau, G.A. (2001) Oligomerization of polyalanine expanded PABPN1 facilitates nuclear protein aggregation that is associated with cell death. Hum. Mol. Genet., 10, 2341\u20132351.","DOI":"10.1093\/hmg\/10.21.2341"},{"key":"key\n\t\t\t\t20171012064608_DDI395C9","unstructured":"Rankin, J., Wyttenbach, A. and Rubinsztein, D.C. (2000) Intracellular green fluorescent protein-polyalanine aggregates are associated with cell death. Biochem. J., 348, 15\u201319."},{"key":"key\n\t\t\t\t20171012064608_DDI395C10","doi-asserted-by":"crossref","unstructured":"Carmichael, J., Chatellier, J., Woolfson, A., Milstein, C., Fersht, A.R. and Rubinsztein, D.C. (2000) Bacterial and yeast chaperones reduce both aggregate formation and cell death in mammalian cells models of Huntington's disease. Proc. Natl Acad. Sci. USA, 97, 9701\u20139705.","DOI":"10.1073\/pnas.170280697"},{"key":"key\n\t\t\t\t20171012064608_DDI395C11","doi-asserted-by":"crossref","unstructured":"Fan, X. and Rouleau, G.A. (2003) Progress in understanding the pathogenesis of oculopharyngeal muscular dystrophy. Can. J. Neurol. Sci., 30, 8\u201314.","DOI":"10.1017\/S0317167100002365"},{"key":"key\n\t\t\t\t20171012064608_DDI395C12","doi-asserted-by":"crossref","unstructured":"Behrouz, F., Enrique, P., Richard, A.H. and Sylvie, E. (1995) Formation of an extremely stable polyalanine \u03b2-sheet macromolecule. Biochem. Biophys. Res. Commun., 211, 7\u201313.","DOI":"10.1006\/bbrc.1995.1770"},{"key":"key\n\t\t\t\t20171012064608_DDI395C13","doi-asserted-by":"crossref","unstructured":"Trottier, Y., Devys, D., Imbert, G., Saudou, F., An, I., Lutz, Y., Weber, C., Agid, Y., Hirsch, E.C. and Mandel, J.L. (1995) Cellular localization of the Huntington's disease protein and discrimination of the normal and mutated form. Nat. Genet., 10, 104\u2013110.","DOI":"10.1038\/ng0595-104"},{"key":"key\n\t\t\t\t20171012064608_DDI395C14","doi-asserted-by":"crossref","unstructured":"Bates, G.P., Mangiarini, L., Mahal, A. and Davis, S.W. (1997) Transgenic models of Huntington's disease. Hum. Mol. Genet., 6, 1633\u20131637.","DOI":"10.1093\/hmg\/6.10.1633"},{"key":"key\n\t\t\t\t20171012064608_DDI395C15","doi-asserted-by":"crossref","unstructured":"Corbeil-Girard, L.P., Klein, A.F., Sasseville, A.M., Lavoie, H., Dicaire, M.J., Saint-Denis, A., Page, M., Duranceau, A., Codere, F., Bouchard, J.P. et\u00a0al. (2005) PABPN1 overexpression leads to upregulation of genes encoding nuclear proteins that are sequestered in oculopharyngeal muscular dystrophy nuclear inclusions. Neurobiol. Dis., 18, 551\u2013567.","DOI":"10.1016\/j.nbd.2004.10.019"},{"key":"key\n\t\t\t\t20171012064608_DDI395C16","doi-asserted-by":"crossref","unstructured":"Hino, H., Araki, K., Uyama, E., Takeya, M., Araki, M., Yoshinobu, K., Mike, K., Kawazoe, Y., Maeda, Y., Uchino, M. and Yamamura, K. (2004) Myopathy phenotype in transgenic mice expressing mutated PABPN1 as a model of oculopharyngeal muscular dystrophy. Hum. Mol. Genet., 13, 181\u2013190.","DOI":"10.1093\/hmg\/ddh017"},{"key":"key\n\t\t\t\t20171012064608_DDI395C17","doi-asserted-by":"crossref","unstructured":"Dion, P., Shanmugam, V., Gaspar, C., Messaed, C., Meijer, I., Toulouse, A., Laganiere, J., Roussel, J., Rochefort, D., Laganier, S. et\u00a0al. (2005) Transgenic expression of an expanded (GCG) (13) repeat PABPN1 leads to weakness and coordination defects in mice. Neurobiol. Dis., 18, 528\u2013536.","DOI":"10.1016\/j.nbd.2004.09.021"},{"key":"key\n\t\t\t\t20171012064608_DDI395C18","doi-asserted-by":"crossref","unstructured":"Andrew, P., Lieberman, M. and Fischbeck, K.H. (2000) Triplet repeat expansion in neuromuscular disease. Muscle Nerve, 23, 843\u2013850.","DOI":"10.1002\/(SICI)1097-4598(200006)23:6<843::AID-MUS2>3.0.CO;2-8"},{"key":"key\n\t\t\t\t20171012064608_DDI395C19","doi-asserted-by":"crossref","unstructured":"Rubinsztein, D.C. (2002) Lessons from animal models of Huntington's diseases. Trends Genet., 18, 202\u2013209.","DOI":"10.1016\/S0168-9525(01)02625-7"},{"key":"key\n\t\t\t\t20171012064608_DDI395C20","doi-asserted-by":"crossref","unstructured":"Bao, Y., Cook, L.J., O'Donovan, D., Uyama, E. and Rubinsztein, D.C. (2002) Mammalian, yeast, bacterial and chemical chaperones reduce aggregate formation and death in a cell model of oculopharyngeal muscular dystrophy. J. Biol. Chem., 277, 12263\u201312269.","DOI":"10.1074\/jbc.M109633200"},{"key":"key\n\t\t\t\t20171012064608_DDI395C21","doi-asserted-by":"crossref","unstructured":"Bao, Y.P., Sarkar, S., Uyama, E. and Rubinsztein, D.C. (2004) Congo red, doxycycline, and HSP70 over expression reduce aggregate formation and cell death in cell models of oculopharyngeal muscular dystrophy. J. Med. Genet., 41, 47\u201351.","DOI":"10.1136\/jmg.2003.014548"},{"key":"key\n\t\t\t\t20171012064608_DDI395C22","doi-asserted-by":"crossref","unstructured":"Lagunas, L., Bradbury, C.M., Laszlo, A., Hunt, C.R. and Gius, D. (2004) Indomethacin and ibuprofen induce hsc70 nuclear localization and activation of the heat shock response in Hela cells. Biochem. Biophys. Res. Commun., 313, 863\u2013870.","DOI":"10.1016\/j.bbrc.2003.12.018"},{"key":"key\n\t\t\t\t20171012064608_DDI395C23","doi-asserted-by":"crossref","unstructured":"Lee, B.S., Chen, J., Angelidis, C., Jurivich, D.A. and Morimoto, R.I. (1995) Pharmacological modulation of heat shock factor 1 by antiinflammatory drugs resulted in protection against stress-induced cellular damage. Proc. Natl Acad. Sci. USA, 92, 7207\u20137211.","DOI":"10.1073\/pnas.92.16.7207"},{"key":"key\n\t\t\t\t20171012064608_DDI395C24","doi-asserted-by":"crossref","unstructured":"Kim, Y.J., Noguchi, S., Hayashi, Y.K., Tsukahara, T., Sahimizu, T. and Arahata, K. (2001) The product of an oculopharyngeal muscular dystrophy gene, poly(A)-binding protein 2, interacts with SKIP and stimulates muscle-specific gene expression. Hum. Mol. Genet., 10, 1129\u20131139.","DOI":"10.1093\/hmg\/10.11.1129"},{"key":"key\n\t\t\t\t20171012064608_DDI395C25","doi-asserted-by":"crossref","unstructured":"Lenk, R., Ransom, L., Kaufmann, Y. and Penman, S. (1977) A cytoskeletal structure with associated polyribosomes from HeLa cells. Cell, 10, 67\u201378.","DOI":"10.1016\/0092-8674(77)90141-6"},{"key":"key\n\t\t\t\t20171012064608_DDI395C26","unstructured":"Burdon, R.H. (1982) The human heat shock proteins: their induction and possible intracellular functions. In Schlesinger, M.J., Ashburner, M. and Tissieres, A. (eds), Heat Shock from Bacteria to Man, Cold Spring Harbor Laboratory, New York, USA."},{"key":"key\n\t\t\t\t20171012064608_DDI395C27","doi-asserted-by":"crossref","unstructured":"Chen, S., Berthelier, V., Yang, W. and Wetzel, R. (2001) Polyglutamine aggregation behave in vitro support a recruitment mechanism of cytotoxicity. J. Mol. Biol., 311,173\u2013182.","DOI":"10.1006\/jmbi.2001.4850"},{"key":"key\n\t\t\t\t20171012064608_DDI395C28","doi-asserted-by":"crossref","unstructured":"Sakahira, H., Breuer, P., Hayer-Hartl, M.K. and Hartl, F.U. (2002) Molecular chaperones as modulators of polyglutamine protein aggregation and toxicity. Proc. Natl Acad. Sci. USA, 99, 16412\u201316418.","DOI":"10.1073\/pnas.182426899"},{"key":"key\n\t\t\t\t20171012064608_DDI395C29","doi-asserted-by":"crossref","unstructured":"Schaffar, G., Breuer, P. and Botera, R. (2004) Cellular toxicity of polyglutamine expansion proteins: mechanism of transcription factor deactivation. Mol. Cell, 15, 95\u2013105.","DOI":"10.1016\/j.molcel.2004.06.029"},{"key":"key\n\t\t\t\t20171012064608_DDI395C30","doi-asserted-by":"crossref","unstructured":"Cumming, C.J., Reinstein, E., Sun, Y., Antalify, B., Jiang, Y., Ciechanovert, A., Orr, H.T., Beaudet, A.L. and Zoghbi, H.Y. (1999) Mutation of the E6-AP ubiquitin ligase reduces nuclear inclusion frequency while accelerating polyglutamine-induced pathology in SCAI mice. Neuron, 24, 879\u2013892.","DOI":"10.1016\/S0896-6273(00)81035-1"},{"key":"key\n\t\t\t\t20171012064608_DDI395C31","doi-asserted-by":"crossref","unstructured":"Saudou, F., Finkbeiner, S., Devys, D. and Greenberg, M.E. (1998) Huntingtin acts in the nucleus to induce apoptosis but death does not correlate with the formation of intranuclear inclusions. Cell, 95, 55\u201366.","DOI":"10.1016\/S0092-8674(00)81782-1"},{"key":"key\n\t\t\t\t20171012064608_DDI395C32","doi-asserted-by":"crossref","unstructured":"Arresate, M., Mitra, S., Schweitzer, E.S., Regal, M.R. and Finkbeiner, S. (2004) Inclusion body formation reduces levels of mutant Huntingtin and the risk of neuronal death. Nature, 431, 805\u2013810.","DOI":"10.1038\/nature02998"},{"key":"key\n\t\t\t\t20171012064608_DDI395C33","doi-asserted-by":"crossref","unstructured":"Mosser, D.D. and Morimoto, R.I. (2004) Molecular chaperones and the stress of oncogenesis. Oncogene, 23, 2907\u20132918.","DOI":"10.1038\/sj.onc.1207529"},{"key":"key\n\t\t\t\t20171012064608_DDI395C34","doi-asserted-by":"crossref","unstructured":"Kelley, P.M. and Schlesinger, M. (1978) The effect of amino acid analogues and heat shock on gene expression in chicken embryo fibroblasts. Cell, 15, 1277\u20131286.","DOI":"10.1016\/0092-8674(78)90053-3"},{"key":"key\n\t\t\t\t20171012064608_DDI395C35","doi-asserted-by":"crossref","unstructured":"Mosser, D.D., Caron, A.W., Bourget, L., Denis-Larose, C. and Massie, B. (1997) Role of the human heat shock protein hsp70 in protection against stress-induced apoptosis. Mol. Cell. Biol., 17, 5317\u20135327.","DOI":"10.1128\/MCB.17.9.5317"},{"key":"key\n\t\t\t\t20171012064608_DDI395C36","doi-asserted-by":"crossref","unstructured":"Hyun, T.H., Barreet-Connor, E. and Milne, D.B. (2004) Zinc intakes and plasma concentrations in men with osteoporosis: The Rancho Bernardo study. Am. J. Clin. Nutr., 80, 715\u2013721.","DOI":"10.1093\/ajcn\/80.3.715"},{"key":"key\n\t\t\t\t20171012064608_DDI395C37","unstructured":"National Toxicology Program (1985) NTP toxicology and carcinogenesis studies of 8-hydroxyquinoline (CAS No: 1482-24-3) in F3441\u2005N rats and B6C3F1 mice (feed studies). Natl Toxicol., Program Tech. Rep. Ser., 276, 1\u2013170."},{"key":"key\n\t\t\t\t20171012064608_DDI395C38","unstructured":"Raether, W. and Hanel, H. (2003) Nitroheterocyslic drugs with broad spectrum activity. Parasitol. Res., 90, S19\u2013S39."},{"key":"key\n\t\t\t\t20171012064608_DDI395C39","doi-asserted-by":"crossref","unstructured":"Gouras, G.K. and Beal, M.F. (2001) Metal chelator decreases Alzheimer \u03b2-amyloid plaques. Neuron, 30, 641\u2013642.","DOI":"10.1016\/S0896-6273(01)00330-0"},{"key":"key\n\t\t\t\t20171012064608_DDI395C40","doi-asserted-by":"crossref","unstructured":"Di Vaira, M., Bazzicalupi, C., Orioli, P., Messori, L., Bruni, B. and Zatta, P. (2004) Clioquinol, a drug for Alzheimer's disease specifically interfering with brain metal metabolism: structural characterization of its zinc(II) and copper(II) complexes. Inorg. Chem., 43, 3795\u20133797.","DOI":"10.1021\/ic0494051"},{"key":"key\n\t\t\t\t20171012064608_DDI395C41","doi-asserted-by":"crossref","unstructured":"Bush, A.I. (2003) The metallobiology of Alzheimer disease. Trends Neurosci., 26, 207\u2013214.","DOI":"10.1016\/S0166-2236(03)00067-5"},{"key":"key\n\t\t\t\t20171012064608_DDI395C42","doi-asserted-by":"crossref","unstructured":"Heiser, V., Engemann, S., Brocker, W., Dunkel, I., Boeddrich, A., Waelter, S., Nordhoff, E., Lurz, R., Schugardt, N., Rautenberg, S. et\u00a0al. (2002) Identification of benzothiazoles as potential polyglutamine aggregation inhibitors of Huntington's disease by using an automated filter retardation assay. Proc. Natl Acad. Sci. USA, 99, 16400\u201316406.","DOI":"10.1073\/pnas.182426599"},{"key":"key\n\t\t\t\t20171012064608_DDI395C43","doi-asserted-by":"crossref","unstructured":"Poirier, M.A., Li, H., Macosko, J., Cai, S., Amzel, M. and Ross, C.A. (2002) Huntingtin spheroids and protofibrils as precursors in polyglutamine fibrilization. J. Biol. Chem., 277, 41032\u201341037.","DOI":"10.1074\/jbc.M205809200"},{"key":"key\n\t\t\t\t20171012064608_DDI395C44","doi-asserted-by":"crossref","unstructured":"Ishihara, K., Yamagishi, N. and Hatayama, T. (2004) Suppression of heat- and polyglutamine-induced cytotoxicity by nonsteroidal anti-inflammatory drugs. Eur. J. Biochem., 271, 4552\u20134558.","DOI":"10.1111\/j.1432-1033.2004.04419.x"},{"key":"key\n\t\t\t\t20171012064608_DDI395C45","doi-asserted-by":"crossref","unstructured":"Bermano, G., Shepherd, R.K., Zehner, Z.E. and Hesketh, J.E. (2001) Perinuclear mRNA localization by vimentin 3\u2032-untranslated region requires a 100 nucleotide sequence and intermediate filaments. FEBS Lett., 497, 77\u201381.","DOI":"10.1016\/S0014-5793(01)02438-3"},{"key":"key\n\t\t\t\t20171012064608_DDI395C46","doi-asserted-by":"crossref","unstructured":"Dreyfuss, G., Adams, S. and Choi, Y.F. (1984) Physical changes in cytoplasmic messenger ribonucleoproteins in cells treated with inhibitors of mRNA transcription. Mol. Cell. Biol., 4, 415\u2013423.","DOI":"10.1128\/MCB.4.3.415"},{"key":"key\n\t\t\t\t20171012064608_DDI395C47","doi-asserted-by":"crossref","unstructured":"Towbin, H. and Gordon, J. (1984) Immunoblotting and dot immunobinding: current status and outlook. J. Immunol. Methods, 72, 313\u2013340.","DOI":"10.1016\/0022-1759(84)90001-2"}],"container-title":["Human Molecular Genetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/hmg\/article-pdf\/14\/23\/3673\/1490103\/ddi395.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,3]],"date-time":"2019-04-03T07:05:07Z","timestamp":1554275107000},"score":1,"resource":{"primary":{"URL":"http:\/\/academic.oup.com\/hmg\/article\/14\/23\/3673\/559467\/Induction-of-HSP70-expression-and-recruitment-of"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,10,20]]},"references-count":47,"journal-issue":{"issue":"23","published-online":{"date-parts":[[2005,10,20]]},"published-print":{"date-parts":[[2005,12,1]]}},"URL":"https:\/\/doi.org\/10.1093\/hmg\/ddi395","relation":{},"ISSN":["1460-2083","0964-6906"],"issn-type":[{"value":"1460-2083","type":"electronic"},{"value":"0964-6906","type":"print"}],"subject":[],"published-other":{"date-parts":[[2005,12,1]]},"published":{"date-parts":[[2005,10,20]]}}}